Latest News about ABUS
Recent news which mentions ABUS
From Benzinga
 From Benzinga
 Tickers 
   ABUS
  
  
  From InvestorPlace
 Tickers 
   ABUS
  
  
  From InvestorPlace
 From InvestorPlace
 From Benzinga
 
   Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Chart Signals Potential Rebound Ahead
   
  
  
  April 04, 2024
  From Benzinga
 
   Arbutus Stock Soars 20% As It Heads To Trial With Moderna In Covid Vaccine Patent Claim
   
  
  
  April 03, 2024
  From Benzinga
 
   Earnings Scheduled For February 29, 2024
   
  
  
  February 29, 2024
  From Benzinga
 
   Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute
   
  
  
  October 05, 2023
  From Benzinga
 
   US Court Favors Moderna In COVID-19 Vaccine Patent Infringement Case With Arbutus Biopharma
   
  
  
  April 12, 2023
  From Benzinga
 
   Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots
   
  
  
  April 04, 2023
  From Benzinga
 
   Arbutus Biopharma's Return On Capital Employed Insights
   
  December 12, 2022
  Tickers 
   ABUS
  
  
  From Benzinga
 From Benzinga
 From InvestorPlace
 
   Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know
   
  
  
  August 26, 2022
  From Benzinga
 
   Arbutus Biopharma (ABUS) Q2 2022 Earnings Call Transcript
   
  August 04, 2022
  Tickers 
   ABUS
  
  
  From Motley Fool
 From Benzinga
 From Benzinga
 
   This Analyst Says Arbutus' EASL Presentations Outline Path For A Functional Cure For Chronic Hepatitis B
   
  
  
  June 28, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.